Recent Updates
Recently added Catalysts
WHWK Positive Sentiment Score: 70/100

Whitehawk Therapeutics to Participate in the BTIG Virtual Biotechnology Conference

Tuesday, July 22, 2025 1 min read
Key Takeaway: Whitehawk Therapeutics, Inc. announced its participation in the upcoming BTIG Virtual Biotechnology Conference scheduled for July 29-30, 2025. The company focuses on developing advanced antibody-drug conjugates (ADCs) to enhance cancer treatment efficacy. This event highlights Whitehawk's ongoing efforts to innovate in oncology therapeutics.

Market Sentiment Analysis

POSITIVE FACTORS

  • Participation in a notable biotechnology conference
  • Showcases Whitehawk's commitment to oncology advancements
  • Opportunity to present innovative ADC cancer treatments

Full Press Release Details

MORRISTOWN, N.J.,July 22, 2025/PRNewswire/ -- Whitehawk Therapeutics, Inc. (Nasdaq:WHWK), an oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver improved ADC cancer treatments, announced today that the Company's management will participate in the BTIG Virtual Biotechnology Conference being held on July 29-30, 2025.

About Whitehawk Therapeutics

Whitehawk Therapeutics is an oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver improved cancer treatments. Whitehawk's advanced three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers. These assets are in-licensed from WuXi Biologics under an exclusive development and global commercialization agreement. More information on the Company is available atwww.whitehawktx.comand connect with us on LinkedIn.

Contact[email protected]

SOURCE Whitehawk Therapeutics, Inc.

Frequently Asked Questions

What is the date of the BTIG Virtual Biotechnology Conference?

The conference will be held on July 29-30, 2025.

What does Whitehawk Therapeutics focus on?

Whitehawk Therapeutics specializes in oncology therapeutics and advanced ADC treatments.

Who is Whitehawk's partner for ADC development?

Whitehawk has an exclusive agreement with WuXi Biologics for ADC development.

Where can I find more information about Whitehawk Therapeutics?

More information is available on their website at www.whitehawktx.com.

Tags: WHWK Viatris Investor Conferences Healthcare Whitehawk Therapeutics oncology biotechnology conference ADC cancer treatments
Last updated: Jul 22, 2025